Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kernt

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|April 2, 2010
[Alkylphosphocholines inhibit lens epithelial cell proliferation and attachment]R Liegl, M Kernt, K Obholzer, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|June 6, 2009
[Protective effect of blue light-absorbing IOLs on the human retinal pigment epithelium]M Kernt, C Hirneiss, A S Neubauer, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|October 15, 2013
[Wide-field fundus autofluorescence in non-infectious posterior uveitis]L Reznicek, F Seidensticker, C Stumpf, et al.
The British Journal of Ophthalmology|October 22, 2010
Sorafenib prevents human retinal pigment epithelium cells from light-induced overexpression of VEGF, PDGF and PlGFM Kernt, A S Neubauer, R G Liegl, et al.
Klinische Monatsblatter Fur Augenheilkunde|December 12, 2012
[Improvement of fixation in diabetic macular oedema patients under intravitreal ranibizumab treatment]F Seidensticker, L Reznicek, S Cserhati, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|February 26, 2013
[Ranibizumab in diabetic macular edema. Evaluation of functional and morphological aspects]L Reznicek, S Cserhati, R Liegl, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|September 17, 2009
[Intracameral moxifloxacin: a safe option for endophthalmitis prophylaxis? In vitro safety profile for intraocular application]M Kernt, C Hirneiss, A S Neubauer, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|April 26, 2012
[Navigated focal retinal laser therapy using the NAVILAS® system for diabetic macula edema]M Kernt, R Cheuteu, R G Liegl, et al.
Growth Factors (Chur, Switzerland)|February 20, 2010
Sorafenib protects human optic nerve head astrocytes from light-induced overexpression of vascular endothelial growth factor, platelet-derived growth factor, and placenta growth factorM Kernt, R G Liegl, J Rueping, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 22, 2011
[Cytoprotective and antiangiogenic effects of the multikinase inhibitor sorafenib on human retinal pigmentepithelium]M Kernt, S Thiele, C Hirneiss, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|April 2, 2010
[Alkylphosphocholines inhibit lens epithelial cell proliferation and attachment]R Liegl, M Kernt, K Obholzer, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|June 6, 2009
[Protective effect of blue light-absorbing IOLs on the human retinal pigment epithelium]M Kernt, C Hirneiss, A S Neubauer, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|October 15, 2013
[Wide-field fundus autofluorescence in non-infectious posterior uveitis]L Reznicek, F Seidensticker, C Stumpf, et al.
The British Journal of Ophthalmology|October 22, 2010
Sorafenib prevents human retinal pigment epithelium cells from light-induced overexpression of VEGF, PDGF and PlGFM Kernt, A S Neubauer, R G Liegl, et al.
Klinische Monatsblatter Fur Augenheilkunde|December 12, 2012
[Improvement of fixation in diabetic macular oedema patients under intravitreal ranibizumab treatment]F Seidensticker, L Reznicek, S Cserhati, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|February 26, 2013
[Ranibizumab in diabetic macular edema. Evaluation of functional and morphological aspects]L Reznicek, S Cserhati, R Liegl, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|September 17, 2009
[Intracameral moxifloxacin: a safe option for endophthalmitis prophylaxis? In vitro safety profile for intraocular application]M Kernt, C Hirneiss, A S Neubauer, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|April 26, 2012
[Navigated focal retinal laser therapy using the NAVILAS® system for diabetic macula edema]M Kernt, R Cheuteu, R G Liegl, et al.
Growth Factors (Chur, Switzerland)|February 20, 2010
Sorafenib protects human optic nerve head astrocytes from light-induced overexpression of vascular endothelial growth factor, platelet-derived growth factor, and placenta growth factorM Kernt, R G Liegl, J Rueping, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 22, 2011
[Cytoprotective and antiangiogenic effects of the multikinase inhibitor sorafenib on human retinal pigmentepithelium]M Kernt, S Thiele, C Hirneiss, et al.
Pageof 3